Dr. Laura Rosella

Scientist
Scientific, Research and Ethics Program

Photo of Dr. Laura Rosella
ON WHY PUBLIC HEALTH ONTARIO IS IMPORTANT

"Being at PHO allows me to be at the interface of world-leading research that is directly used in public health policy and practice. Seeing the results of my research in action is the ultimate motivation; more importantly, I get a better appreciation of what the research needs are from the people that are using it so I can design my work accordingly."

Areas of Expertise

  • epidemiological methods
  • applied biostatistics
  • population-based risk tools to support public health planning
  • diabetes and obesity
  • public health policy
  • premature mortality
  • socioeconomic gradients in health

Academic Degrees and Accreditations

  • Doctor of Philosophy (Epidemiology), Dalla Lana School of Public Health, University of Toronto
  • Master of Health Sciences (Epidemiology and Community Health), Dalla Lana School of Public Health, University of Toronto

PHO Research Interests

  • Support and evaluate public health activities across various content areas, including chronic and infectious disease.
  • Studying the social and health determinants of premature mortality. 
  • Studying population-based approaches to reducing diabetes and obesity.
  • Inform population intervention strategies using Population Risk Tools (PoRTs).  
  • Provide ongoing methodological and analytical support to PHO scientists for Institute for Clinical Evaluative Sciences’ (ICES) related projects.

PHO Research Activities

  • Population health analytics in action: Improving impact, sustainability & equity of the health care system.
  • Quantifying future risk and burden of type 2 diabetes in Canada.
  • Investigating biomarkers for type 2 diabetes and pre-diabetes.
  • Investigating the characteristics and upstream determinants of high-cost users of Ontario’s health care system. 
  • Examining partnerships to guide the adaption, implementation, and evaluation of DPoRT within local (e.g., public health units), provincial (e.g., Ministry of Health and Long-Term Care), and Canadian context. 
  • The ORAD (Oral Health and Diabetes) Study.
  • Neighbourhood walkability and chronic disease risk in Canada.
  • Hepatitis B in migrants and the general population in Ontario in 2010-12.

Selected Publications

  1. Khan AM, Urquia M, Kornas K, Henry D, Cheng SY, Bornbaum C, Rosella LC. Socioeconomic gradients in all-cause, premature and avoidable mortality using among immigrants and long-term residents using linked deaths records in Ontario, Canada. J Epidemiol Community Health. 2017;71:625-32.
  2. Rosella LC, Calzavara A, Frank J, Fitzpatrick T, Donnelly P. Henry D. Narrowing mortality gap between men and women over two decades: a registry-based study in Ontario, Canada. BMJ Open. 2016;6(11):e012564.
  3. Rosella LC, Bowman C, Pach B, Morgan S, Fitzpatrick T, Goel V. The development and validation of a meta-tool for quality appraisal of public health evidence: Meta Quality Appraisal Tool (MetaQAT). Public Health. 2016;136:57-65.
  4. Rosella LC, Lebenbaum M, Fitzpatrick T, O’Riley D, Wang J, Booth GL, Stukel TA, Wodchis W. Impact of diabetes on healthcare costs in a population-based cohort: A cost analysis. Diabet Med. 2016;33(3):395-403.
  5. Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL. The prevalence of prediabetes and undiagnosed diabetes in Canada (2007-2011): according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care. 2015;38(7):1299-305.

View more publications by Dr. Laura Rosella on PubMed.gov

Public Health Ontario Scientist Profile: Laura Rosella

Dr. Laura Rosella discusses what excites her about her work, the impact of her research and why she chose Public Health Ontario.

Duration: 2 min

Chat icon

Contact

media@oahpp.ca

Updated 22 Oct 2019